Averill Madison Master Fund, Ltd. has filed 1 Form 4 with the SEC that we hold, all for Benitec Biopharma Inc. (BNTC), as Director, 10% owner. Across all of them we count 6 purchases worth $539.0K and 0 sales worth $0 reported on Form 4. In the last 12 months: 6 purchases ($539.0K) and 0 sales ($0). The largest single trade was a purchase of 16,650 shares of Benitec Biopharma Inc. worth $201.1K, dated 2025-12-22. The first filing on our record is dated 2025-12-22 and the latest 2025-12-22.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-18 | P, purchase reported on Form 4 | 8,700 | $97.8K | 2025-12-22 |
| 2025-12-18 | P, purchase reported on Form 4 | 1,515 | $17.0K | 2025-12-22 |
| 2025-12-19 | P, purchase reported on Form 4 | 2,434 | $27.9K | 2025-12-22 |
| 2025-12-19 | P, purchase reported on Form 4 | 13,950 | $160.1K | 2025-12-22 |
| 2025-12-22 | P, purchase reported on Form 4 | 16,650 | $201.1K | 2025-12-22 |
| 2025-12-22 | P, purchase reported on Form 4 | 2,892 | $34.9K | 2025-12-22 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2021243) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.